Myofibroblasts in nasal polyposis: Regulation by topical steroids

Canadian Respiratory Journal

Volumn 4, Issue 4, 1997, Pages 205-210

  Tremblay, Guy M ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Fibroblasts; Immunochemistry; Nasal polyps; Transforming growth factor beta

Indexed keywords

ALPHA ACTIN; BECLOMETASONE DIPROPIONATE; BUDESONIDE; CORTICOSTEROID; CYTOKINE; TRANSFORMING GROWTH FACTOR BETA; VIMENTIN;

ADULT; AGED; ARTICLE; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE; MYOFIBROBLAST; NOSE POLYP; PHENOTYPE; POLYPECTOMY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TOPICAL DRUG ADMINISTRATION;

EID: 0030874160     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/1997/901819     Document Type: Article

References (2)

1. Jordana M, Dolovich J, Ohno I, Finotto S, Denburg J. Nasal polyposis: A model for chronic inflammation. In: Busse WW, Holgate ST, eds. Asthma and Rhinitis. Boston: Blackwell Scientific Publications, 1995:156-64.
2. Jankowski R, Béné MC, Moneret-Vautrin AD, et al. Immunohistological characteristics of nasal polyps. A comparison with healthy mucosa and chronic sinusitis. Rhinology 1989;Supp 8:51-8.